Post by Orbia Fluor & Energy Materials

In this new article from Pharmaceutical Manufacturing and Packing Sourcer (PMPS), our Head of Pharma Business Unit, Markus Laubscher delves into the reasons why low-GWP propellants for use in pMDIs offer a viable alternative to traditional propellants and also DPIs, without sacrificing patient outcomes.   Discover his findings in this insightful article in the new issue of PMPS on pages 24-26. Read the full article: https://lnkd.in/eAwhwcsY #LowGWPTransition #LowGWPPropellant #Zephex #SustainabilityinPharma #HFA152a